Logo image of SENS

SENSEONICS HOLDINGS INC (SENS) Stock Fundamental Analysis

NYSEARCA:SENS - US81727U1051 - Common Stock

0.4574 USD
+0.02 (+5.37%)
Last: 8/22/2025, 8:04:00 PM
0.4588 USD
+0 (+0.31%)
After Hours: 8/22/2025, 8:04:00 PM
Fundamental Rating

2

SENS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. While SENS seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, SENS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SENS had negative earnings in the past year.
SENS had a negative operating cash flow in the past year.
In the past 5 years SENS reported 4 times negative net income.
SENS had a negative operating cash flow in each of the past 5 years.
SENS Yearly Net Income VS EBIT VS OCF VS FCFSENS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

The Return On Assets of SENS (-45.39%) is worse than 65.78% of its industry peers.
SENS has a Return On Equity (-72.01%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -45.39%
ROE -72.01%
ROIC N/A
ROA(3y)-13.99%
ROA(5y)-136.34%
ROE(3y)-16.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SENS Yearly ROA, ROE, ROICSENS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K

1.3 Margins

The Gross Margin of SENS (17.77%) is worse than 81.28% of its industry peers.
The Profit Margin and Operating Margin are not available for SENS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SENS Yearly Profit, Operating, Gross MarginsSENS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K

More info and screens

4

2. Health

2.1 Basic Checks

SENS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SENS has been increased compared to 1 year ago.
Compared to 5 years ago, SENS has more shares outstanding
SENS has a worse debt/assets ratio than last year.
SENS Yearly Shares OutstandingSENS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
SENS Yearly Total Debt VS Total AssetsSENS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

SENS has an Altman-Z score of -5.62. This is a bad value and indicates that SENS is not financially healthy and even has some risk of bankruptcy.
SENS has a worse Altman-Z score (-5.62) than 70.59% of its industry peers.
SENS has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
SENS has a Debt to Equity ratio of 0.37. This is comparable to the rest of the industry: SENS outperforms 45.99% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z -5.62
ROIC/WACCN/A
WACC8.79%
SENS Yearly LT Debt VS Equity VS FCFSENS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

2.3 Liquidity

SENS has a Current Ratio of 9.58. This indicates that SENS is financially healthy and has no problem in meeting its short term obligations.
SENS's Current ratio of 9.58 is amongst the best of the industry. SENS outperforms 91.44% of its industry peers.
A Quick Ratio of 9.26 indicates that SENS has no problem at all paying its short term obligations.
The Quick ratio of SENS (9.26) is better than 92.51% of its industry peers.
Industry RankSector Rank
Current Ratio 9.58
Quick Ratio 9.26
SENS Yearly Current Assets VS Current LiabilitesSENS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.08% over the past year.
The Revenue has been growing slightly by 5.94% in the past year.
The Revenue has been growing slightly by 1.08% on average over the past years.
EPS 1Y (TTM)23.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)5.94%
Revenue growth 3Y18.01%
Revenue growth 5Y1.08%
Sales Q2Q%36.67%

3.2 Future

Based on estimates for the next years, SENS will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.21% on average per year.
SENS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 50.35% yearly.
EPS Next Y19.53%
EPS Next 2Y13.33%
EPS Next 3Y9.7%
EPS Next 5Y17.21%
Revenue Next Year62.85%
Revenue Next 2Y63.46%
Revenue Next 3Y61.81%
Revenue Next 5Y50.35%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SENS Yearly Revenue VS EstimatesSENS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
SENS Yearly EPS VS EstimatesSENS Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 -0.4 -0.6 -0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SENS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SENS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SENS Price Earnings VS Forward Price EarningsSENS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SENS Per share dataSENS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.33%
EPS Next 3Y9.7%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SENS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SENSEONICS HOLDINGS INC

NYSEARCA:SENS (8/22/2025, 8:04:00 PM)

After market: 0.4588 +0 (+0.31%)

0.4574

+0.02 (+5.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners10.87%
Inst Owner Change74.89%
Ins Owners3.5%
Ins Owner Change5.16%
Market Cap363.10M
Analysts76.67
Price Target1.44 (214.82%)
Short Float %6.49%
Short Ratio7.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.35%
Min EPS beat(2)1.96%
Max EPS beat(2)14.75%
EPS beat(4)3
Avg EPS beat(4)9.2%
Min EPS beat(4)-14%
Max EPS beat(4)34.09%
EPS beat(8)6
Avg EPS beat(8)7.97%
EPS beat(12)7
Avg EPS beat(12)-0.74%
EPS beat(16)11
Avg EPS beat(16)63.45%
Revenue beat(2)2
Avg Revenue beat(2)9.27%
Min Revenue beat(2)8.25%
Max Revenue beat(2)10.29%
Revenue beat(4)4
Avg Revenue beat(4)6.13%
Min Revenue beat(4)2.48%
Max Revenue beat(4)10.29%
Revenue beat(8)7
Avg Revenue beat(8)5.36%
Revenue beat(12)10
Avg Revenue beat(12)4.93%
Revenue beat(16)11
Avg Revenue beat(16)2.84%
PT rev (1m)-29.37%
PT rev (3m)-1.45%
EPS NQ rev (1m)8.35%
EPS NQ rev (3m)38.9%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-7.83%
Revenue NQ rev (3m)-15.69%
Revenue NY rev (1m)1.76%
Revenue NY rev (3m)1.76%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 14.26
P/FCF N/A
P/OCF N/A
P/B 3.83
P/tB 3.87
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.03
BVpS0.12
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -45.39%
ROE -72.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.77%
FCFM N/A
ROA(3y)-13.99%
ROA(5y)-136.34%
ROE(3y)-16.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 22.67%
Cap/Sales 1.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.58
Quick Ratio 9.26
Altman-Z -5.62
F-Score5
WACC8.79%
ROIC/WACCN/A
Cap/Depr(3y)70.29%
Cap/Depr(5y)48.74%
Cap/Sales(3y)4.48%
Cap/Sales(5y)3.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y19.53%
EPS Next 2Y13.33%
EPS Next 3Y9.7%
EPS Next 5Y17.21%
Revenue 1Y (TTM)5.94%
Revenue growth 3Y18.01%
Revenue growth 5Y1.08%
Sales Q2Q%36.67%
Revenue Next Year62.85%
Revenue Next 2Y63.46%
Revenue Next 3Y61.81%
Revenue Next 5Y50.35%
EBIT growth 1Y11.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year20.93%
EBIT Next 3Y12.25%
EBIT Next 5YN/A
FCF growth 1Y21.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.05%
OCF growth 3YN/A
OCF growth 5YN/A